TY - JOUR
T1 - Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index
T2 - A study protocol for a before/after intervention with a retrospective control group and multiple case analysis
AU - Dearing, Marci Elizabeth
AU - Bowles, Susan
AU - Isenor, Jennifer
AU - Kits, Olga
AU - Kouladjian O'Donnell, Lisa
AU - Neville, Heather
AU - Hilmer, Sarah
AU - Toombs, Kent
AU - Sirois, Caroline
AU - Hajizadeh, Mohammad
AU - Negus, Aprill
AU - Rockwood, Kenneth
AU - Reeve, Emily
N1 - Funding Information:
Contributors MED and ER contributed to the concept and design of this study and this manuscript, drafted the manuscript, revised the manuscript based on coauthor feedback and approved the final version for submission. SB, JI, KT, OK, LKO, HN, SH, CS, MH, AN and KR contributed to the concept and design of this study and this manuscript, reviewed the manuscript and approved the final version for submission. Funding This work was supported by the Canadian Frailty Network 2017 Catalyst Grant Competition, grant number CAT2017-13. In addition, funding for the follow-up phase was supported by the Nova Scotia Health Authority Research Fund and the Dalhousie (University) Pharmacy Endowment Fund. ER is supported by an NHMRC-ARC Dementia Research Development Fellowship. disclaimer The funders had no role in the study design; collection, management, analysis and interpretation of data; writing of the report; or the decision to submit the report for publication.
Publisher Copyright:
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/2/20
Y1 - 2020/2/20
N2 - Introduction Polypharmacy and potentially inappropriate medication use is common in older adults and is associated with adverse outcomes such as falls and hospitalisations. Methods and analysis This study is a pharmacist-led medication optimisation initiative using an electronic tool (the Drug Burden Index (DBI) Calculator) in four hospital sites in the Canadian province of Nova Scotia. The study aims to enrol 160 participants between the preintervention and intervention groups. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013 checklist) was used to develop the protocol for this prospective interventional implementation study. A preintervention retrospective control cohort and a multiple case study analysis will also be used to assess the effect of intervention implementation. Statistical analysis will involve change in DBI scores and assessment of clinical outcomes, such as rehospitalisation and mortality using appropriate statistical tests including t-test, χ 2, analysis of variance and unadjusted and adjusted regression methods. Ethics and dissemination Ethics approval has been granted by the Nova Scotia Health Authority Research Ethics Board. The findings of this study will be published in peer-reviewed journals and presented at local, national and international conferences. Trial registration number NCT03698487.
AB - Introduction Polypharmacy and potentially inappropriate medication use is common in older adults and is associated with adverse outcomes such as falls and hospitalisations. Methods and analysis This study is a pharmacist-led medication optimisation initiative using an electronic tool (the Drug Burden Index (DBI) Calculator) in four hospital sites in the Canadian province of Nova Scotia. The study aims to enrol 160 participants between the preintervention and intervention groups. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013 checklist) was used to develop the protocol for this prospective interventional implementation study. A preintervention retrospective control cohort and a multiple case study analysis will also be used to assess the effect of intervention implementation. Statistical analysis will involve change in DBI scores and assessment of clinical outcomes, such as rehospitalisation and mortality using appropriate statistical tests including t-test, χ 2, analysis of variance and unadjusted and adjusted regression methods. Ethics and dissemination Ethics approval has been granted by the Nova Scotia Health Authority Research Ethics Board. The findings of this study will be published in peer-reviewed journals and presented at local, national and international conferences. Trial registration number NCT03698487.
KW - adverse events
KW - clinical pharmacology
KW - geriatric medicine
UR - http://www.scopus.com/inward/record.url?scp=85079741795&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2019-035656
DO - 10.1136/bmjopen-2019-035656
M3 - Article
C2 - 32086361
AN - SCOPUS:85079741795
SN - 2044-6055
VL - 10
JO - BMJ Open
JF - BMJ Open
IS - 2
M1 - 035656
ER -